Examination Report |
1 | TM-1 | 25 Jun 2014 |
2 | Reply to Exam Report (MIS-R) | 04 May 2017 |
3 | Reply to Exam Report (MIS-R) | 08 May 2017 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 27 Mar 2018 |
5 | Journal Copy | 21 Jun 2018 |
6 | Certificate | 23 Aug 2018 |
7 | TM-R(RENEWAL OF TRADE MARK) | 24 Jun 2024 |
1 | Dispatching of Examination Report for : 2762127 | 2940179 | 1506145 | 28 Jan 2016 |
2 | Dispatching of Examination Report for : 2762127 | 2940175 | 1506145 | 28 Jan 2016 |
3 | Abandoned Order for Application No 2762127 | 3412899 | 1781337 | 31 Mar 2016 |
4 | Hearing Notice (Show Cause) | 5928861 | 2672925 | 20 Feb 2018 |
5 | Tribunal Accepted Notice for : 2762127 | 6139185 | 2759472 | 28 Mar 2018 |
6 | O3 NOTICE | 17972404 | 6730215 | 16 Apr 2024 |
7 | RENEWAL INTIMATION LETTER | 18402683 | 27 Jun 2024 |
The application for Tendomac was made on 25 June 2014.
The trademark applicant for Tendomac is MACLEODS PHARMACEUTICALS.
Tendomac is applied in class(es) 5.
Application for Tendomac is on Registered stage.
Application Id allotted to Tendomac is 2762127.
Trademark agent or attorney for the application is Singh & Singh Law Firm Llp.
Tendomac filed with the Intellectual property office as a DEVICE.